A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

March 7, 2008

Genetically Reprogrammed Cells Could Battle HIV

Genetically reprogramming infection-fighting cells known as CD8 cytotoxic T lymphocytes (CTLs) made them especially efficient at wiping out HIV in laboratory experiments, report researchers at the Albert Einstein College at Yeshiva University in the Bronx, New York.

CTLs play a major role fighting HIV in the body by recognizing and killing CD4 cells that are infected with the virus. When HIV infects CD4 cells, small pieces of viral proteins are displayed on the surface of the cell, allowing CTLs to identify and destroy them. Unfortunately, most people living with HIV do not develop a CTL response that is sufficiently potent to control HIV replication. There are, however, a small group of people living with HIV, known as “elite controllers,” who are able to maintain undetectable viral loads without the help of antiretroviral drugs—sometimes indefinitely.

Harris Goldstein, MD, and his colleagues at Yeshiva University theorized that the CTLs of elite controllers may have special properties that make them particularly good at killing infected CD4 cells. They found that these “super CTLs,” as Dr. Goldstein describes them, had receptors that were able to bind very tightly to infected cells and to recognize the viral proteins on the cell surface.

Dr. Goldstein’s team next isolated some of the genes responsible for these hyper-efficient receptors found on the CTLs from elite HIV controllers. The group then bound the genes to a lentivirus, so that they could be effectively delivered into the nuclei of CTLs that do not naturally carry the genes. Once the CTLs began expressing the more efficient receptors, Dr. Goldstein’s team infused them into mice, along with HIV-infected human cells.

After one week, the researchers report, the infected cells had been almost completely destroyed.

Dr. Goldstein intends to locate other genes responsible for boosting the HIV-fighting effectiveness of super CTLs. This may involve reprogramming CTLs using multiple genes, just as HIV-positive people are currently treated with multiple antiretrovirals at one time.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 7 (of 7 total)    

j p, pico, 2008-03-20 07:46:31
Is there any clinical trials on the way and if so how can I take part?

Pitla, South Africa, 2008-03-13 02:37:42
I cannnot wait for this treatment, i am sick and tired of taking this ARV's everyday at the same time the rest of my life, this is burden, even on holidays.May God give this Doctors more courage to do their research

Robert, Miami, 2008-03-12 13:34:42
When will these things be available ? I can't wait!

dave, , 2008-03-12 13:12:18
again i just hope they put a rush on this because as many of you have been reading the articles above..more and more of us are being infected everyday! Theres no time in "taking time" to find a cure..this is an urgent matter!

ithink, nj, 2008-03-11 08:31:47
the piece of hiv foreign protien is inserted on the supercell CD8. auto immune response like asthma is fighting the bodies natural defenses, not genetic. like having the wrong blood transfused. i think

Liyth, , 2008-03-11 02:45:15
This a great acheivement in the hestory of HIV treatment, it could be a new step toward finding a cure for this virus.

wondering?, atl, 2008-03-09 09:50:51
how does this work if u happen to have lupus or other auto diseases?

comments 1 - 7 (of 7 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    j_powell01
    Bakersfield
    California


    Savannahman78
    Topeka
    Kansas


    astoria85
    nyc
    New York


    Valmont
    Daytona Beach
    Florida
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.